Molecular imaging of neuroendocrine neoplasms
The key for molecular imaging is the use of a radiotracer with a radioactive and a functional
component. While the functional component targets a specific feature of the tumor, the …
component. While the functional component targets a specific feature of the tumor, the …
[HTML][HTML] Impact of cold somatostatin analog administration on somatostatin receptor imaging: a systematic review
D Morland, N Laures, EKA Triumbari… - Clinical Nuclear …, 2023 - journals.lww.com
Purpose The interactions between the administration of cold somatostatin analogs (cSAs)
and their radiolabeled counterpart remain unclear, and discontinuation before imaging is …
and their radiolabeled counterpart remain unclear, and discontinuation before imaging is …
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
This ENETS guidance paper aims to provide practical advice to clinicians for the diagnosis,
treatment and follow-up of functioning syndromes in pancreatic neuroendocrine tumours …
treatment and follow-up of functioning syndromes in pancreatic neuroendocrine tumours …
[HTML][HTML] Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
F Grawe, N Rosenberger, M Ingenerf, L Beyer… - Cancer Imaging, 2023 - Springer
Background The aim of this retrospective study was to compare the diagnostic accuracy of
somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of …
somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of …
Insulinoma
WW de Herder - Neuroendocrinology, 2004 - karger.com
More than 90% of insulinomas are benign tumors. Insulinomas cause hypoglycemia and
thereby symptoms of neuroglycopenia and catecholamine response. During symptoms …
thereby symptoms of neuroglycopenia and catecholamine response. During symptoms …
[HTML][HTML] Interventional vs surgical procedures in localized/nonmetastatic insulinomas (ablation vs surgery)
A Sada, TJ McKenzie, A Vella, MJ Levy… - Endocrine-Related …, 2023 - erc.bioscientifica.com
Localized insulinoma is an uncommon entity that can result in substantial morbidity due to
the associated hypoglycemia. Recent studies have suggested an increase in the incidence …
the associated hypoglycemia. Recent studies have suggested an increase in the incidence …
[HTML][HTML] Insulinoma
F Zhuo, C Anastasopoulou - 2019 - europepmc.org
Objectives: Describe the typical presenting symptoms of insulinoma. Review the evaluation
of insulinoma, including appropriate biochemical tests and localization modalities …
of insulinoma, including appropriate biochemical tests and localization modalities …
Molecular Imaging in neuroendocrine neoplasias
Molecular imaging, which uses molecular targets due to the overexpression of specific
peptide hormone receptors on the tumour surface, has become an indispensable diagnostic …
peptide hormone receptors on the tumour surface, has become an indispensable diagnostic …
Role of 68Ga-DOTATOC PET/CT in insulinoma according to 3 different contexts: a retrospective study
PL Moreau, C Aveline, S Christin-Maitre… - Clinical Nuclear …, 2022 - journals.lww.com
Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Dif... : Clinical Nuclear
Medicine Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Different Contexts: A …
Medicine Role of 68Ga-DOTATOC PET/CT in Insulinoma According to 3 Different Contexts: A …
[HTML][HTML] Role of Exendin-4 Functional Imaging in Diagnosis of Insulinoma: A Systematic Review
MMA Sidrak, MS De Feo, F Corica, J Gorica, M Conte… - Life, 2023 - mdpi.com
Background: Insulinomas are the most common neuroendocrine neoplasms of the
pancreas. Diagnosis is made through patient clinical presentation with hypoglycemia …
pancreas. Diagnosis is made through patient clinical presentation with hypoglycemia …